Making "Cents" of When and How to Do an Economic Analysis: Approaches to Keep the Interest of Stakeholders

Saturday, April 26, 2025

1:00pm – 2:30pm HST

Location: Convention Center: 307

CE: CME: 1.5
Ethics CME: 1.5

Leader(s)

Alex Kemper, MD, MPH, MS (he/him/his)

Professor
Department of Pediatrics
Nationwide Children's Hospital
Columbus, Ohio, United States

Co-Leader(s)

Alyna Chien, MD, MS

Associate Professor, Research Director
Division of General Pediatrics
Boston Children's Hospital / Harvard Medical Schoo
Boston, Massachusetts, United States
Naomi Bardach, MD, MAS (she/her/hers)

Professor of Pediatrics and Health Policy
Pediatrics
University of California, San Francisco, School of Medicine
San Francisco, California, United States
AR

Andrew Racine, MD PhD

Professor of Pediatrics
Albert Einstein College of Medicine/Montefiore Health System
NEW YORK, New York, United States
Alison Galbraith, MD, MPH (she/her/hers)

Professor and Director, Division of Health Services Research
Boston Medical Center and Boston University School of Medicine
Boston, Massachusetts, United States

Disclosure(s):

Alex R. Kemper, MD, MPH, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Kelly J. Kelleher, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Alyna (LN Chien, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Naomi S. Bardach, MD, MAS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Andrew D. Racine, MD PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Alison A. Galbraith, MD, MPH: Harvard Pilgrim Health Care/Point32 Health (Terminated, January 31, 2023) (Products/Services: Employment with an ineligible company, Research Support including clinical trials & the principal or named investigator)

Workshop Description: In the United States, pediatric healthcare policies are rarely guided by economic analyses. However, timely well-conducted economic analyses could lead to better policy decisions at all levels (e.g., local clinic and health system, state, and federal). This workshop will begin with an interactive session exploring how economic analysis have and could potentially influence decisions by Medicaid policy makers and how cost analyses are used within health systems and at the practice level. Participants will then be presented with a wide range of economic analysis types (e.g., simple cost analysis, cost-effectiveness analysis, cost-benefit analysis) from different perspectives (e.g., family, health system, society) and consider how they might be used to inform policy nationally and locally. The workshop will explore how implications are different based on type of analysis and perspective. For any particular intervention, the economic implications for Medicaid might be far different than for a health system or a clinic. The workshop will then conclude with small groups using a structured format to discuss their own work, which could include anything from local quality-improvement to policy advocacy, and whether and how they could include an economic assessment. The small group format will provide an opportunity for participants to practice making presentations of potential economic analyses to policymakers (health system, payer, or legislative).

Learning Objectives:

Describe how economic analyses could be used by policy makers at the national, state, and local levels.
Select the type of economic analysis most relevant for their own work.
Demonstrate an ability to effectively communicate the results of economic analyses to the stakeholders they wish to influence.